Market Share of Ankylosing Spondylitis Treatment
The ankylosing spondylitis treatment market is moderately competitive with several players across the globe. The majority of the key player is involved in the research and manufacturing of ankylosing spondylitis therapy drugs. These market players have gained a high market share and offer a wide range of products with an extensive distribution system across the world. Some of the major key players are Novartis, Amgen, Boehringer Ingelheim International GmbH, UCB Biopharma, and AbbVie.
Ankylosing Spondylitis Treatment Market Leaders
Novartis AG
AbbVie Inc.
Amgen Inc.
Boehringer Ingelheim International GmbH
UCB S.A.
*Disclaimer: Major Players sorted in no particular order
